Disease | colorectal cancer |
Symptom | C0746883|febrile neutropenia |
Sentences | 1 |
PubMedID- 20378503 | A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapy. |
Page: 1